Vascular最新文献

{"title":"Early outcome of percutaneous mechanical thrombectomy using the AcoStream device in combination with other endovascular therapies for deep vein thrombosis in a lower extremity.","authors":"Zuanbiao Yu, Tiequan Yang, Ming Cai, Songjie Hu, Di Wang, Yafang Shao, Dehai Lang","doi":"10.1177/17085381251347865","DOIUrl":"https://doi.org/10.1177/17085381251347865","url":null,"abstract":"<p><p>ObjectiveTo evaluate the efficacy and safety of the AcoStream device (Acotec Scientific, Beijing, China) when used in combination with other endovascular therapies in patients with deep vein thrombosis (DVT) in a lower extremity.MethodsThis single-center retrospective study included 126 consecutive patients who were treated for DVT at our institution between December 2022 and August 2024. Mechanical aspiration of thrombus using the AcoStream device was performed under local anesthesia in all cases. Residual thrombus of >30% after aspiration mechanical thrombectomy was treated by catheter-directed thrombolysis. Percutaneous balloon dilatation and stent implantation were performed in the event of residual iliac vein stenosis of >50%. We analyzed related indices during aspiration mechanical thrombectomy and evaluated the early outcome during follow-up.ResultsTechnical success (>70% resolution of thrombus) was achieved in 110 patients (87.3%). Seventy-six patients (60.3%) also underwent catheter-directed thrombolysis (mean duration 4.47 ± 2.69 days and mean urokinase dose 33.19 ± 9.58 *10,000 IU per day), and 71 (56.3%) also underwent balloon dilatation and stent implantation. The mean decrease in hemoglobin after aspiration mechanical thrombectomy was 15.20 ± 10.21 g/L. There were no major complications. The median follow-up duration was 7.87 ± 3.56 months. The primary patency rate was 92.9% (117/126). Thrombus recurred in five patients (in-stent thrombosis, <i>n</i> = 4; re-thrombosis, <i>n</i> = 1) and was treated successfully by catheter-directed thrombolysis. Post-thrombotic syndrome occurred in 7.1% of patients, including one with a venous ulcer.ConclusionsThe findings of this study indicate that use of the AcoStream device combined with other endovascular therapies is a feasible and effective treatment for DVT with a high technical success rate and satisfactory short-term results.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251347865"},"PeriodicalIF":1.0,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of paclitaxel-coated balloon angioplasty in prolonging arteriovenous fistula patency: A retrospective analysis from a single center in Latin America.","authors":"Monica S Ponce-Rivera, Jose G Ajila-Vacacela, Jorge Flores-Orduña, Mario O'Connor, Paulina Elizabeth Cisneros Clavijo, Mario Alejandro Fabiani","doi":"10.1177/17085381251345540","DOIUrl":"https://doi.org/10.1177/17085381251345540","url":null,"abstract":"<p><p>IntroductionArteriovenous fistula (AVF) is the preferred method for vascular access. However, fistulas can fail and may develop stenosis. Therefore, maintaining the patency of the access is vital. Balloon angioplasty has been accepted as the first-line treatment for central venous stenosis. However, the reintervention rate with plain balloon angioplasty (PBA) is high. Drug-coated balloons (DCB) have emerged as a promising therapy for effectively prolonging the patency of treated vessels and reducing the reintervention rate. This study aims to determine the 12-month patency of arteriovenous fistulas following paclitaxel-coated balloon (PCB) angioplasty for central and peripheral venous stenosis.MethodsThis single-center retrospective analysis included patients with end-stage renal disease who underwent hemodialysis via native arteriovenous fistulas. The information was collected from medical records and compiled into a de-identified database provided by the institution. All patients were included regardless of sex or age, provided they had an angiography demonstrating central or peripheral venous stenosis and were treated with PCB. Patients were followed up every 3 months for 12 months at the vascular center. The primary objective was to ensure the vascular access was functioning effectively for hemodialysis and to monitor for any complications.ResultsA total of 137 patients with AVF dysfunction were treated with PCB; among them, 111 (81%) had central venous stenosis and 26 (19%) had peripheral venous stenosis. There was no significant difference in patency rates at 12-month follow-up between central (79%) and peripheral (85%) accesses. Factors associated with non-patency at 12-month follow-up were exhausted access (HR = 0.21, 95% IC 0.09-0.47, <i>p</i> < .001) and stenosis length greater than 20 mm (HR = 0.33, 95% IC 0.15-0.72, <i>p</i> = .005).ConclusionsThe high patency rate at 12 months for dysfunctional AVFs indicated that treatment with PCB is highly effective in both central and peripheral vein stenosis.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251345540"},"PeriodicalIF":1.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Accuracy of point-of-care-ultrasound performed by physicians in the diagnosis of deep vein thrombosis.","authors":"Serhat Örün, Cihan Aydın, Aykut Demirkıran, Mehmet Çelik","doi":"10.1177/17085381251342387","DOIUrl":"https://doi.org/10.1177/17085381251342387","url":null,"abstract":"<p><p>BackgroundThe diagnosis of deep vein thrombosis (DVT) is usually made by a sonographer using a thorough Doppler ultrasound. The current study examined whether emergency resident physicians could accurately diagnose DVT using a point-of-care, three-point compression protocol.MethodsThe patient population consisted of patients with suspected DVT who presented to the emergency department between 2021 and 2022. All patients underwent a three-point compression ultrasound exam by the emergency resident. Each patient then had a comprehensive whole-leg ultrasonography exam performed by a supervisor emergency specialist. The results of the ultrasound exams by the emergency resident physicians and comprehensive exams were then analyzed and compared.ResultsThe average age of the patients was 60,96 ± 16,67. There was a statistically significant difference between three-point compression and whole-leg ultrasound examination data. The negative predictive value of the resident physician was determined as 94%. The coefficient of the compression variable in the Ridge regression analysis for diagnosing DVT in the whole-leg ultrasound examination was obtained as -0.3754.ConclusionsWe think that compression ultrasonography may be sufficient in patient management compared to whole-leg ultrasonography in emergency management. However, we think that three-point compression ultrasonography applied by the emergency resident is quite successful in diagnosing and excluding DVT in the emergency department.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251342387"},"PeriodicalIF":1.0,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of statins on restenosis after carotid artery stenting.","authors":"Berna Keskin, Onur Ergun, Erdem Birgi, Işık Conkbayır, Erdi Tangobay, Mehmet Fevzi Öztekin, Baki Hekimoğlu","doi":"10.1177/17085381251342343","DOIUrl":"https://doi.org/10.1177/17085381251342343","url":null,"abstract":"<p><p>ObjectiveCarotid artery stenting is a minimally invasive procedure often chosen to treat carotid artery stenosis. In-stent restenosis is a well-known complication of this procedure. Statins, primarily recognized for their role in lowering LDL cholesterol, have been demonstrated to reduce in-stent restenosis following coronary artery stenting. This effect is often attributed to their pleiotropic properties rather than solely their impact on LDL cholesterol. Given that neointimal hyperplasia is the mechanism underlying in-stent restenosis in both coronary and carotid artery stenting, this study aims to investigate the effects of statins on in-stent restenosis in patients undergoing carotid artery stenting, as well as to identify factors that contribute to restenosis.MethodsThe study included 51 patients who underwent carotid artery stenting. Data collected included the patients' age, gender, presence of hypertension, diabetes mellitus, hyperlipidemia, smoking history, post-procedure smoking, statin use, plaque morphologies, and Doppler and NASCET stenosis rates. Follow-ups were performed at 3rd and 6th months post-procedure. Maximum LDL cholesterol levels and HbA1c levels were measured at the 6-month follow-up. Intima-media thickness within the stent lumen was assessed, and restenosis was evaluated based on spectral Doppler findings.ResultsIn our study, according to the measurements obtained from the in-stent segment, restenosis was detected in 5 patients (9.8%) overall. After the procedure, 37 patients (72.5%) were on statins, while 14 (27.5%) were not. Restenosis occurred in 4 patients (28.6%) in the non-statin group and 1 patient (2.7%) in the statin group, with a statistically significant difference (<i>p</i> = .017). All patients in the non-statin group had maximum LDL cholesterol levels ≥100 mg/dl during the follow-up. In the statin group, 67.6% of patients had maximum LDL cholesterol levels ≥100 mg/dl, while 32.4% of patients had <100 mg/dl. The difference was found statistically significant (<i>p</i> = .022). All 5 patients who developed restenosis had left-sided stents, and the difference between the groups was found to be close to statistical significance (<i>p</i> = .051). No significant differences were found between groups concerning other factors influencing restenosis and neointimal hyperplasia (<i>p</i> > .05).ConclusionsOur study is the first in the literature to demonstrate that statin use is effective in preventing the development of restenosis in patients who underwent carotid artery stenting. This effect appears to occur independently of LDL cholesterol levels and is attributed to the pleiotropic effects of statins. Based on the data obtained, we believe that statin use after the procedure may reduce restenosis rates, regardless of LDL cholesterol levels.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251342343"},"PeriodicalIF":1.0,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144111473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Physician-modified endografts and carotid-subclavian bypass in the treatment of extensive thoracic aortic aneurysm involving the aortic arch.","authors":"Guangmin Yang, Guangyan Wu, Yepeng Zhang, Min Zhou","doi":"10.1177/17085381251342330","DOIUrl":"https://doi.org/10.1177/17085381251342330","url":null,"abstract":"<p><p>ObjectivesThoracic aortic aneurysm (TAA) involving the aortic arch poses a significant risk of cerebrovascular accidents and presents technical challenges for repair. This report presents a hybrid approach combining carotid-subclavian bypass (CSbp) and physician-modified endografts (PMEGs) for a patient with extensive aortic arch involvement.MethodA 77-year-old asymptomatic man with a large TAA extending into the aortic arch underwent a hybrid procedure. The intervention included a CSbp and the deployment of a double-fenestrated PMEG, prepared using a Valiant Captivia stent-graft platform, with additional branches to accommodate supra-aortic vessels.ResultsThe patient's intraoperative and postoperative course was uneventful, with no neurological or vascular complications. Follow-up CTA at 1 year showed a patent carotid-subclavian bypass, well-positioned stent grafts, and no evidence of endoleak or graft migration.ConclusionThe combination of carotid-subclavian bypass and PMEGs offers a feasible and effective treatment for complex TAA involving the aortic arch, particularly in high-risk patients unsuitable for open repair or total endovascular approaches.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251342330"},"PeriodicalIF":1.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Eluvia stent in endovascular treatment of femoropopliteal occlusive disease: Early results of the challenge study.","authors":"Yiting Xu, Bing Wang, Chenyang Qiu, Qiang Li, Meng Ye, Zhenyu Shi, Xin Fang, Chunshui He, Zibo Feng, Hongfei Sang, Lianrui Guo, Ziheng Wu","doi":"10.1177/17085381251342326","DOIUrl":"https://doi.org/10.1177/17085381251342326","url":null,"abstract":"<p><p>ObjectivesThe aim of this study was to evaluate the one-year results of the Eluvia drug-eluting vascular stent (Boston Scientific, Marlborough, MA, USA) for the treatment of femoropopliteal occlusive disease (FPOD).MethodsFrom January 2021 to November 2023, this multicenter study prospectively enrolled patients with peripheral artery disease involving the femoropopliteal artery. The primary outcome measures were the rate of freedom from clinically driven target limb revascularization (f-CD-TLR), rate of freedom from major adverse events (f-MAE), rate of freedom from symptom recurrence (f-SR) and rate of freedom from all-cause death (f-ACD). The secondary outcome measures were the Rutherford grade and Vascular Quality of Life (VascuQoL) scale scores.ResultsIn total, 159 patients were enrolled in this study. The mean follow-up time was 370 days, and the follow-up rate was 83.0%. The patients' mean age was 72 years, and 82.4% were male. A total of 159 patients received 199 stent deployments. The mean lesion length was 194.4 ± 118.9 mm, and 76.7% had total occlusions. The technical success rate for endovascular treatment was 100%, and five complications occurred during the perioperative period. At one, three, six, and 12 months, the f-CD-TLR rate was 99.3%, 97.9%, 96.4%, and 92.8%, respectively; the f-MAE rate was 98.0%, 96.7%, 93.1%, and 91.3%, respectively; the f-SR rate was 94.6%, 85.5%, 80.3%, and 73.4%, respectively; and the f-ACD rate was 98.0%, 98.0%, 95.9% and 94.1%, respectively. There was a substantial increase in the Rutherford grade and average VascuQoL scores at the one-, three-, six-, and 12-month follow-ups (<i>p</i> < .001).ConclusionsThe Eluvia stent had a favorable effect on FPOD throughout 12 months of follow-up. Further studies with larger sample sizes and longer-term follow-up are required to confirm the real-world performance of the Eluvia stent.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251342326"},"PeriodicalIF":1.0,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Superficial femoral artery disease as a cardiovascular prognostic predictor in aortoiliac revascularization-A cohort study.","authors":"Ana Sofia-Goncalves, Diogo Domingues-Monteiro, Tiago Costa- Pereira, António Pereira-Neves, Hugo Ribeiro, José Vidoedo, Joao Rocha-Neves","doi":"10.1177/17085381251341086","DOIUrl":"https://doi.org/10.1177/17085381251341086","url":null,"abstract":"<p><p>IntroductionAortoiliac disease is a severe manifestation of peripheral artery disease (PAD) that reduces blood flow to the lower limbs, leading to significant morbidity and mortality. Patients with AID frequently present lesions in other arterial territories, particularly in the superficial femoral artery (SFA), which may lead to more challenging and higher risk outcomes in patients. This study aims to evaluate the prognostic value for major adverse cardiovascular events (MACE) of SFA disease in patients undergoing aortoiliac revascularization.MethodsThis prospective cohort study included all consecutive patients who underwent elective aortoiliac revascularization between January 2013 and September 2022 at both a central and a district hospital, representing two healthcare facilities within the Portuguese Health System. Only patients with aortoiliac Transatlantic Inter-Society Consensus (TASC) II type D lesions were included, excluding those with aortoiliac aneurysmal disease. Moreover, patients with severe multivessel disease in other arterial areas, apart from the aortoiliac artery and SFA, were excluded. Patient demographics, clinical characteristics, and procedural details were collected. Outcomes were assessed in the first 30 days post-procedure and during long-term follow-up. Statistical analyses included Kaplan-Meier survival curves and multivariate Cox regression.ResultsA total of 133 patients were included, with a mean age of 62.3 ± 9.23 years; 94.0% were male, and a median follow-up of 61 [IQR: 55.0-67.0] months. SFA disease was present in 60.9% of patients and was associated with hypertension (<i>p</i> = .025), coronary artery disease (<i>p</i> = .005), congestive heart failure (<i>p</i> = .020), and age (<i>p</i> = .008). Patients with SFA disease had a lower 30-day ankle-brachial index (ABI) (<i>p</i> < .001), smaller post-surgery ABI variation (<i>p</i> = .003), longer hospital stays (<i>p</i> = .005), and higher rates of major adverse limb event (MALE) (<i>p</i> = .007). Survival analysis demonstrated increased long-term MALE, MACE, and all-cause mortality in patients with SFA disease. Multivariable analysis confirmed SFA disease as a significant predictor of all-cause mortality (HR = 2.046 [1.042-4.443] <i>p</i> = .048) and suggested a trend towards increased risk of MACE (HR = 1.542, [0.866-3.101], <i>p</i> = .075).ConclusionThis study identifies SFA disease as a critical prognostic marker for adverse cardiovascular outcomes in patients undergoing aortoiliac revascularization. Further research with larger sample sizes and longer follow-up periods is warranted to validate these findings and improve patient management strategies.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251341086"},"PeriodicalIF":1.0,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143988336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The accumulation of epicardial adipose tissue is associated with cardiovascular death after open surgical repair for abdominal aortic aneurysms.","authors":"Yohei Kawai, Masayuki Sugimoto, Takuya Osawa, Changi Lee, Shuta Ikeda, Kiyoaki Niimi, Hiroshi Banno","doi":"10.1177/17085381251342332","DOIUrl":"https://doi.org/10.1177/17085381251342332","url":null,"abstract":"<p><p>BackgroundThe accumulation of adipose tissue, such as increased epicardial adipose tissue volume (EATV) and visceral fat area (VFA), is associated with the development of cardiovascular (CV) disease. However, little information is available regarding the relationship between EATV and CV death in patients who undergo open surgical repair (OSR) for abdominal aortic aneurysms (AAAs). The aim of this study was to evaluate the association between adipose tissue and CV death and to identify factors related to CV death after AAA repair.MethodsBetween June 2005 and December 2019, a total of 739 patients underwent OSR for AAA with or without iliac artery aneurysm and isolated iliac artery aneurysm at our institution. AAA with a diameter of 50 mm or more and iliac artery aneurysm with 35 mm or greater were considered to be a surgical indication. Patients with ruptured AAAs and infected AAAs were excluded. Four hundred ninety-two patients with preoperative optimal computed tomography (CT) scans were included in this study. The EATV, VFA, and subcutaneous fat area (SFA) were retrospectively quantified from preoperative noncontrast CT images. The EATV index was defined as the EATV divided by the body surface area, and the VFA index and SFA index were defined as each number divided by height squared. The correlations among the EATV, VFA, and SFA indices were analyzed, and the cut-off values of the parameters for predicting CV death after OSR for AAA patients were determined via receiver operating characteristic curves. Regression analysis was used to assess predictors of CV death during the follow-up period. Cox hazard regression analysis was performed.ResultsThe median age was 71 years, and 12% of the patients were female. The median body mass index was 23.1 kg/m². The prevalence of comorbidities was 31% for coronary artery disease, 9% for stroke, 15% for diabetes, and 41% for chronic kidney disease. The median follow-up period for overall patients was 62.5 months (interquartile range: 33.7-99.6). The EATV index was positively correlated with the VFA (R = 0.615, <i>p</i> < .001) and SFA (R = 0.421, <i>p</i> < .001) indices. The cut-off value of the EATV index was 73.8 cm³/m² (area under the curve (AUC); 0.566). Multivariate analysis revealed that age ≥75 years and an EATV index ≥73.8 cm³/m² were significantly associated with CV death after AAA repair.ConclusionsThis study demonstrated that the EATV index was associated with CV death in patients who underwent OSR for AAA, suggesting its potential utility as a novel risk stratification tool for personalized postoperative management.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251342332"},"PeriodicalIF":1.0,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144014482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Varicose vein in patients under the age of 40: A multicenter case-control study.","authors":"Jing Tu, Xinwei Li, Lirui Huang, Jinhong Sun, Xiang Wang, Pengfu Xu, Yulin Chen, Wenjun Zhao, Ziheng Wu, Yun Pan, Chenyang Qiu","doi":"10.1177/17085381251340885","DOIUrl":"https://doi.org/10.1177/17085381251340885","url":null,"abstract":"<p><p>ObjectiveTo assess the risk factors for varicose veins in patients under the age of 40 and the long-term results of surgery.MethodsThis multicenter case-control study comprised patients who received great saphenous vein stripping and ambulatory phlebectomy between January 2014 and December 2015 and were followed for at least 5 years. Patients under the age of 40 were assigned to Group 1. Patients in Group 2 were selected in a 3:1 ratio by matching their CEAP classification to those in Group 1. We studied their demographics, risk factors, and follow-up findings.ResultsThere were 42 patients (mean age 35) in Group 1 and 126 patients (mean age 57) in Group 2. Group 2 patients had a higher prevalence of hypertension (16% vs 2%, <i>p</i> = .022). The proportions of C2, C3, C4, C5, and C6 were 52%, 10%, 24%, 10%, and 5%, respectively. For risk factors, only family history was more prevalent in Group 1 (odds ratio 4.9, 95% confidence interval 2.3-10.4). The course of the disease was shorter in Group 1 (<i>p</i> = .003). During a mean follow-up of 79 months, there were no difference in the recurrences of varicose vein, Venous Clinical Severity Score, or Aberdeen Varicose Vein Questionnaire scores (<i>p</i> > .05), which indicated similar 5-year surgery efficacy between the two groups.ConclusionFamily history was more prevalent and the course of the disease was shorter among young patients with varicose veins. The 5-year prognosis of surgery was satisfactory despite the age of receiving the treatment.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251340885"},"PeriodicalIF":1.0,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144016041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ultrasound-guided popliteal sciatic nerve block versus traditional analgesia for early perioperative pain relief in severe chronic lower extremity arterial occlusive disease: A retrospective study.","authors":"Jie Zhang, Zeyi Zhao","doi":"10.1177/17085381251339937","DOIUrl":"https://doi.org/10.1177/17085381251339937","url":null,"abstract":"<p><p>ObjectiveChronic lower extremity arterial occlusive disease (LEAO) presents significant diagnostic and management challenges, often requiring effective perioperative pain management to enhance patient outcomes. This study evaluated the efficacy of ultrasound-guided popliteal sciatic nerve block (PSNB) compared to traditional analgesia in managing early perioperative pain and improving microcirculation in patients with severe LEAO.MethodsThis retrospective, exploratory study involved 92 patients with Fontaine classification III and IV LEAO, treated from January 2021 to December 2022. Patients were divided into two groups: those receiving traditional analgesia with fentanyl patches and those undergoing PSNB. Clinical outcomes assessed included early perioperative pain intensity using the Visual Analogue Scale (VAS), Toe-Brachial Index (TBI), foot temperature (FT), and feet transcutaneous oxygen pressure (FTpO2). Data on tramadol usage and results from lower limb ultrasound post-analgesia were also collected.ResultsPSNB was associated with significantly lower VAS scores and higher TBI, foot temperature, and transcutaneous oxygen pressure compared to traditional analgesia, indicating enhanced pain management and microcirculation. Furthermore, PSNB patients showed a significantly reduced consumption of tramadol and improved collateral circulation in the lower limbs as evaluated on the fifth day post-analgesia.ConclusionPSNB provides superior pain control and enhances microcirculatory outcomes in the early perioperative period for patients with severe LEAO, presenting a promising alternative to traditional analgesic methods. These findings suggest that PSNB has the potential to improve early perioperative management in LEAO, although further research is needed to confirm these results across broader populations.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251339937"},"PeriodicalIF":1.0,"publicationDate":"2025-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144001790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}